Basit öğe kaydını göster

Effects of Polymorphisms in Interferon λ 3 (Interleukin 28B) onSustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

dc.contributor.authorBesisik, Fatih
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorDemir, Kadir
dc.contributor.authorOnel, Mustafa
dc.contributor.authorSoyer, Ozlem Mutluay
dc.contributor.authorEvirgen, Sami
dc.contributor.authorYilmaz, Emre
dc.contributor.authorKaraca, Cetin
dc.contributor.authorOnel, Derya
dc.contributor.authorOrmeci, Asli Cifcibasi
dc.contributor.authorGokturk, Suut
dc.contributor.authorBaran, Bulent
dc.date.accessioned2021-03-03T20:33:34Z
dc.date.available2021-03-03T20:33:34Z
dc.date.issued2014
dc.identifier.citationYilmaz E., Baran B., Soyer O. M. , Onel M., Onel D., Ormeci A. C. , Gokturk S., Evirgen S., Akyuz F., Demir K., et al., "Effects of Polymorphisms in Interferon λ 3 (Interleukin 28B) onSustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection", Clinical Gastroenterology and Hepatology, cilt.12, sa.10, ss.1753-1758, 2014
dc.identifier.issn1542-3565
dc.identifier.othervv_1032021
dc.identifier.otherav_5a863132-a892-45bb-9275-cf4bfc905858
dc.identifier.urihttp://hdl.handle.net/20.500.12627/63615
dc.identifier.urihttps://doi.org/10.1016/j.cgh.2014.01.043
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84908111464&origin=inward
dc.description.abstractBACKGROUND & AIMS: We investigated the association between interferon lambda 3 (IFNL3) genotype (also known as interleukin 28B) and response to IFN alpha therapy in patients with chronic hepatitis D virus (HDV) infection.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectİç Hastalıkları
dc.subjectKlinik Tıp
dc.titleEffects of Polymorphisms in Interferon λ 3 (Interleukin 28B) onSustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection
dc.typeMakale
dc.relation.journalClinical Gastroenterology and Hepatology
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume12
dc.identifier.issue10
dc.identifier.startpage1753
dc.identifier.endpage1758
dc.contributor.firstauthorID217163


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster